Intravesical Botulinum Toxin A Injections in Treatment of Interstitial Cystitis Refractory to Conventional Treatment
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This study was designed in a multicenter, randomized, double-blind, placebo controlled trial
to test the actual therapeutic effects of intravesical BoNTA injection. The results of this
study might provide clinical evidence for a better therapeutic regimen in the treatment of
IC/PBS.
Phase:
Phase 2
Details
Lead Sponsor:
Buddhist Tzu Chi General Hospital
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA